| Authors: |
Jakacki RI; Children's Hospital of Pittsburgh, University of Pittsburgh, 4401 Penn Ave., Pittsburgh, PA, 15224, USA. regina.jakacki@astrazeneca.com.; AstraZeneca, One Medimmune Way, Gaithersburg, MD, 20878, USA. regina.jakacki@astrazeneca.com., Foley MA; Astellas Pharma Global Development, 1 Astellas Way, Northbrook, IL, 60062, USA., Horan J; Novella Clinical, 4840 Pearl E Cir # 100, Boulder, CO, 80301, USA., Wang J; Astellas Pharma Global Development, 1 Astellas Way, Northbrook, IL, 60062, USA., Kieran MW; Pediatric Neuro-Oncology, Dana-Farber Cancer Institution, Boston Children's Hospital, 450 Brookline Ave., D-3154, Boston, MA, 02215, USA., Bowers DC; Department of Pediatrics, University of Texas Southwestern Medical School, 5323 Harry Hines Blvd, Dallas, TX, 75390, USA., Bouffet E; The Hospital for Sick Kids, 555 University Avenue, Toronto, ON, M5G 1X8, Canada., Zacharoulis S; The Royal Marsden Hospital, Downs Road, Sutton, Surrey, SM2 5PT, UK., Gill SC; Astellas Pharma Global Development, 1 Astellas Way, Northbrook, IL, 60062, USA. |